The largest database of trusted experimental protocols

Mirna reverse transcription control mirtc

Manufactured by Qiagen

The miRTC (miRNA reverse transcription control) is a laboratory equipment product from Qiagen. It is a control included in Qiagen's miRNA reverse transcription kits, designed to monitor the efficiency of the reverse transcription process for miRNA analysis.

Automatically generated - may contain errors

2 protocols using mirna reverse transcription control mirtc

1

miRNA Quantification by RT-qPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Real-time quantitative PCR (RT-qPCR) validation analysis was performed using the StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA, United States) and the miScript PCR System (Qiagen) according to the manufacturer’s instructions. For miRNA abundance level detection, 250 ng of the total RNA were converted into complementary DNA (cDNA). The resulting cDNA was then diluted to have 0.5 ng/μL input material for miRNA detection. All RT-qPCR experiments were carried out using the Liquid Handling Robot QIAgility (Qiagen) before performing RT-qPCR. All primer assays used in the current study were provided by Qiagen. Moreover, miRNA reverse transcription control (miRTC) (Qiagen) was performed to assess the performance of the reverse transcription reaction. The melting curve analysis was used to control the specificity of RT-qPCR products. Specificity of amplicons was further confirmed by agarose gel electrophoresis.
+ Open protocol
+ Expand
2

RT-qPCR Validation of miRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA) and the miScript PCR System (Qiagen) were used to perform RT-qPCR validation of miRNA expression. All steps were performed according to the manufacturer’s instructions. The same samples used for microarray analysis were also used for RT-qPCR validation. Five miRNAs (miR-1231, miR-3127, miR-3198, miR-135b3p, miR-519e-5p) were chosen for RT-qPCR based on the significance of their abundance (highest fold-change) and biological significance in cardiovascular diseases9 (link),44 (link). Of the total RNA, 250 ng were converted into complementary DNA (cDNA). The resulting cDNA was diluted to 0.5 ng/μL, which was used for miRNA expression analysis. All PCR experiments were carried with the Liquid Handling Robot QIAgility (Qiagen). Primer assays were obtained from Qiagen. A miRNA reverse transcription control (miRTC) (Qiagen) was performed to assess the performance of the reverse transcription reaction. The melting curve analysis was used to determine the specificity of RT-qPCR products.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!